Scott Solomon, MD

Harvard University
Human Biology II, Population Pharmacology

Scott D. Solomon, MD is the Director of Noninvasive Cardiac Laboratory and Cardiac Imaging Program at Brigham and Women’s Hospital. Dr. Solomon’s focuses on echocardiographic assessment of cardiac structure and function in patients with heart failure, post myocardial infarction, attenuating left ventricular remodeling and the effects of inhibitors of the renin-angiotensin-aldosterone system on cardiac structure and function. He has published over 120 original research papers, chapters, reviews, and editorials on these topics and is a world-renowned clinical trialist and has led the cross trial safety analysis of celecoxib.